We retrospectively reviewed the files of 19 extracorporeal life support (ECLS) applications performed after cardiac surgery in 15 patients from January 2002 to December 2004. We placed 16 arteriovenous ECLS applications with oxygenator, 2 venovenous ECLS applications with oxygenator, and 1 biventricular ECLS application without oxygenator (graft dysfunction after heart transplant). Mean age was 4.9 +/- 7 years (median 5.9 months, range 11 days to 21 years). All patients underwent surgery for congenital heart disease, except for one patient who had a heart transplant. Indications were hemodynamic failure in 12 cases, respiratory failure in 5 cases, and mixed failure in 2 cases. Four patients were undergoing cardiopulmonary resuscitation during ECLS placement (no deaths). Mean delay between surgery and ECLS placement was 3.2 +/- 3.4 days (median 2 days). Mean ECLS duration was 3.4 +/- 5.8 days (mean 6 days, range 3-16 days). Three patients had further surgery for residual lesions. Thirteen patients (86.7%) survived to ECLS weaning; 12 patients survived to hospital discharge (80%). No survivor presented obvious neurologic damage. Specific morbidity included reentry for bleeding, multiple transfusions, and mediastinitis. These results support early placement of ECLS in children whenever a severe postoperative hemodynamic or respiratory failure, refractory to medical treatment, is present.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mat.0000178039.53714.57DOI Listing

Publication Analysis

Top Keywords

ecls applications
12
failure cases
12
ecls
9
extracorporeal life
8
life support
8
cardiac surgery
8
applications oxygenator
8
heart transplant
8
respiratory failure
8
ecls placement
8

Similar Publications

Establishing an Extracorporeal Cardiopulmonary Resuscitation Program.

Medicina (Kaunas)

December 2024

Department of Health Science, Anesthesia and ICU, School of Medicine, University of Basilicata San Carlo Hospital, 85100 Potenza, Italy.

Extracorporeal cardiopulmonary resuscitation (ECPR) is a complex, life-saving procedure that uses mechanical support for patients with refractory cardiac arrest, representing the pinnacle of extracorporeal membrane oxygenation (ECMO) applications. Effective ECPR requires precise patient selection, rapid mobilization of a multidisciplinary team, and skilled cannulation techniques. Establishing a program necessitates a cohesive ECMO system that promotes interdisciplinary collaboration, which is essential for managing acute cardiogenic shock and severe pulmonary failure.

View Article and Find Full Text PDF

Inhalable nitric oxide (iNO) is a lifesaving, FDA-approved drug to improve oxygenation in persistent pulmonary hypertension of the newborn. iNO also has many other applications in lung diseases owing to its vasodilatory and antimicrobial effects. However, its wider therapeutic application is often prohibited by the high cost and logistical barriers of traditional NO/N gas tanks.

View Article and Find Full Text PDF
Article Synopsis
  • Mechanical circulatory support devices, especially the microaxial flow pump (mAFP), are being increasingly used to treat patients with cardiogenic shock resulting from acute myocardial infarction, with trials showing mixed results on their effectiveness.* -
  • A comparative analysis of mortality rates from the DanGer-SHOCK and ECLS-SHOCK trials revealed that the mAFP strategy correlated with a notable reduction in mortality at both 30 days and 6 months, suggesting it provides significant benefits over standard care.* -
  • The findings indicate that the DanGer unloading strategy, particularly when combined with percutaneous coronary intervention, enhances long-term survival in patients experiencing cardiogenic shock, although further research is necessary to validate these results across diverse patient groups
View Article and Find Full Text PDF

Extracorporeal membrane oxygenation (ECMO) to support neonates and children with cardiopulmonary failure was first described in the 1970s, since which time its use has expanded to an increasingly complex and heterogenous pediatric population. Despite preserved survival outcomes, complications of ECMO use, including iatrogenic vascular injury, are common. Here, we provide a brief overview of the epidemiology of pediatric ECMO and associated vascular complications; describe common peripheral cannulation equipment and techniques, trends in cannulation and decannulation strategies, and respective incidence of vascular complications; and review existing evidence for best practices in cannula site selection, cannulation technique, decannulation strategies, and management of vascular complications, with the goal of providing a comprehensive review for interventionalists involved in the care of pediatric ECMO patients.

View Article and Find Full Text PDF

Clinical outcomes of challenging out-of-hospital hypothermia management: A retrospective assessment of DOKEI protocol.

Am J Emerg Med

November 2024

Association for Mountain Medical Rescue Japan, Odorinishi28-3-5, Chuou-ku, Sapporo City 064-0820, Hokkaido, Japan.

Background: Accidental hypothermia (AH) is a major cause of death in mountainous areas globally, and the second highest of mountaineering deaths in Japan, accounting for 37 % in Hokkaido. Managing AH is a significant challenge, particularly when adverse weather complicates the application of recommended rewarming and rapid transfer. To address this, the Hokkaido Police Organization (DOKEI) AH protocol was applied in Hokkaido's remote areas from 2011 to 2022, integrating high-temperature active external rewarming (HT-AER) with on-site sustained treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!